Global Biomaterials Market

Biomaterials Comprehensive Study by Type (Metallic Biomaterials (Stainless Steel, Titanium & Titanium Alloys, Cobalt-Chrome Alloys, Gold, Silver, Magnesium), Polymeric Biomaterials (Polymethylmethacrylate, Polyethylene, Polyester, Polyvinylchloride, Silicone Rubber, Nylon, Other), Ceramic Biomaterials (Calcium Phosphate, Zirconia, Aluminum Oxide, Calcium Sulfate, Carbon, Glass), Natural Biomaterials (Hyaluronic Acid, Collagen, Gelatin, Fibrin, Cellulose, Chitin, Alginates, Silk)), Application (Cardiovascular, Orthopedic, Ophthalmology, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Neurology, Others), End User (Hospitals, Laboratories, Research Institutions, Other) Players and Region - Global Market Outlook to 2027

Biomaterials Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Biomaterials play an integral role in medicine today like restoring function and facilitating healing for people after injury or disease. Biomaterials are natural or synthetic and are used in medical applications to support, augment, or replace damaged tissue or a biological function. The first historical usage of biomaterials dates to antiquity when ancient Egyptians used sutures made from animal sinew. The recent field of biomaterials syndicates medicine, biology, physics, and chemistry, and more current influences from tissue engineering and materials science. The field has grown significantly in the past decade due to discoveries in tissue engineering, regenerative medicine, and more.
This growth is primarily driven by Increased Investment and Support by Government Bodies for the Development of Novel Biomaterials and Growing Incidence of Cardiovascular Diseases Worldwide.

Globally, a noticeable market trend is evident Growing Demand for Implantable Devices . Major Players, such as Royal DSM (Netherlands), BASF SE (Germany), Corbion (Netherlands), Evonik Industries (Germany), Zimmer Biomet Holdings, Inc. (United States), Berkeley Advanced Biomaterials (United States), Cam Bioceramics B.V. (Netherlands), Bayer AG (Germany), Collagen Matrix, Inc. (United States) and Victrex plc (United Kingdom) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Market Drivers
  • Increased Investment and Support by Government Bodies for the Development of Novel Biomaterials
  • Growing Incidence of Cardiovascular Diseases Worldwide

Market Trend
  • Growing Demand for Implantable Devices
  • Increasing Demand for Biomaterials in Plastic Surgery and Wound Healing Applications

Restraints
  • Strict Clinical & Regulatory Processes

Opportunities
Growing Healthcare Infrastructure in Emerging Economies
Challenges
Deficiency of Skilled Surgeons

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Biomaterials Study Sheds Light on
— The Biomaterials Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Biomaterials industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Biomaterials industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Metallic Biomaterials [Stainless Steel, Titanium & Titanium Alloys, Cobalt-Chrome Alloys, Gold, Silver, Magnesium]
  • Polymeric Biomaterials [Polymethylmethacrylate, Polyethylene, Polyester, Polyvinylchloride, Silicone Rubber, Nylon, Other]
  • Ceramic Biomaterials [Calcium Phosphate, Zirconia, Aluminum Oxide, Calcium Sulfate, Carbon, Glass]
  • Natural Biomaterials [Hyaluronic Acid, Collagen, Gelatin, Fibrin, Cellulose, Chitin, Alginates, Silk]
By Application
  • Cardiovascular
  • Orthopedic
  • Ophthalmology
  • Dental
  • Plastic Surgery
  • Wound Healing
  • Tissue Engineering
  • Neurology
  • Others
By End User
  • Hospitals
  • Laboratories
  • Research Institutions
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Investment and Support by Government Bodies for the Development of Novel Biomaterials
      • 3.2.2. Growing Incidence of Cardiovascular Diseases Worldwide
    • 3.3. Market Challenges
      • 3.3.1. Deficiency of Skilled Surgeons
    • 3.4. Market Trends
      • 3.4.1. Growing Demand for Implantable Devices
      • 3.4.2. Increasing Demand for Biomaterials in Plastic Surgery and Wound Healing Applications
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Biomaterials, by Type, Application, End User and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Biomaterials (Value)
      • 5.2.1. Global Biomaterials by: Type (Value)
        • 5.2.1.1. Metallic Biomaterials [Stainless Steel, Titanium & Titanium Alloys, Cobalt-Chrome Alloys, Gold, Silver, Magnesium]
        • 5.2.1.2. Polymeric Biomaterials [Polymethylmethacrylate, Polyethylene, Polyester, Polyvinylchloride, Silicone Rubber, Nylon, Other]
        • 5.2.1.3. Ceramic Biomaterials [Calcium Phosphate, Zirconia, Aluminum Oxide, Calcium Sulfate, Carbon, Glass]
        • 5.2.1.4. Natural Biomaterials [Hyaluronic Acid, Collagen, Gelatin, Fibrin, Cellulose, Chitin, Alginates, Silk]
      • 5.2.2. Global Biomaterials by: Application (Value)
        • 5.2.2.1. Cardiovascular
        • 5.2.2.2. Orthopedic
        • 5.2.2.3. Ophthalmology
        • 5.2.2.4. Dental
        • 5.2.2.5. Plastic Surgery
        • 5.2.2.6. Wound Healing
        • 5.2.2.7. Tissue Engineering
        • 5.2.2.8. Neurology
        • 5.2.2.9. Others
      • 5.2.3. Global Biomaterials by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Laboratories
        • 5.2.3.3. Research Institutions
        • 5.2.3.4. Other
      • 5.2.4. Global Biomaterials Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Biomaterials (Volume)
      • 5.3.1. Global Biomaterials by: Type (Volume)
        • 5.3.1.1. Metallic Biomaterials [Stainless Steel, Titanium & Titanium Alloys, Cobalt-Chrome Alloys, Gold, Silver, Magnesium]
        • 5.3.1.2. Polymeric Biomaterials [Polymethylmethacrylate, Polyethylene, Polyester, Polyvinylchloride, Silicone Rubber, Nylon, Other]
        • 5.3.1.3. Ceramic Biomaterials [Calcium Phosphate, Zirconia, Aluminum Oxide, Calcium Sulfate, Carbon, Glass]
        • 5.3.1.4. Natural Biomaterials [Hyaluronic Acid, Collagen, Gelatin, Fibrin, Cellulose, Chitin, Alginates, Silk]
      • 5.3.2. Global Biomaterials by: Application (Volume)
        • 5.3.2.1. Cardiovascular
        • 5.3.2.2. Orthopedic
        • 5.3.2.3. Ophthalmology
        • 5.3.2.4. Dental
        • 5.3.2.5. Plastic Surgery
        • 5.3.2.6. Wound Healing
        • 5.3.2.7. Tissue Engineering
        • 5.3.2.8. Neurology
        • 5.3.2.9. Others
      • 5.3.3. Global Biomaterials by: End User (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Laboratories
        • 5.3.3.3. Research Institutions
        • 5.3.3.4. Other
      • 5.3.4. Global Biomaterials Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Biomaterials (Price)
      • 5.4.1. Global Biomaterials by: Type (Price)
  • 6. Biomaterials: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Royal DSM (Netherlands)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. BASF SE (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Corbion (Netherlands)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Evonik Industries (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Zimmer Biomet Holdings, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Berkeley Advanced Biomaterials (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cam Bioceramics B.V. (Netherlands)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bayer AG (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Collagen Matrix, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Victrex plc (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Biomaterials Sale, by Type, Application, End User and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Biomaterials (Value)
      • 7.2.1. Global Biomaterials by: Type (Value)
        • 7.2.1.1. Metallic Biomaterials [Stainless Steel, Titanium & Titanium Alloys, Cobalt-Chrome Alloys, Gold, Silver, Magnesium]
        • 7.2.1.2. Polymeric Biomaterials [Polymethylmethacrylate, Polyethylene, Polyester, Polyvinylchloride, Silicone Rubber, Nylon, Other]
        • 7.2.1.3. Ceramic Biomaterials [Calcium Phosphate, Zirconia, Aluminum Oxide, Calcium Sulfate, Carbon, Glass]
        • 7.2.1.4. Natural Biomaterials [Hyaluronic Acid, Collagen, Gelatin, Fibrin, Cellulose, Chitin, Alginates, Silk]
      • 7.2.2. Global Biomaterials by: Application (Value)
        • 7.2.2.1. Cardiovascular
        • 7.2.2.2. Orthopedic
        • 7.2.2.3. Ophthalmology
        • 7.2.2.4. Dental
        • 7.2.2.5. Plastic Surgery
        • 7.2.2.6. Wound Healing
        • 7.2.2.7. Tissue Engineering
        • 7.2.2.8. Neurology
        • 7.2.2.9. Others
      • 7.2.3. Global Biomaterials by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Laboratories
        • 7.2.3.3. Research Institutions
        • 7.2.3.4. Other
      • 7.2.4. Global Biomaterials Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Biomaterials (Volume)
      • 7.3.1. Global Biomaterials by: Type (Volume)
        • 7.3.1.1. Metallic Biomaterials [Stainless Steel, Titanium & Titanium Alloys, Cobalt-Chrome Alloys, Gold, Silver, Magnesium]
        • 7.3.1.2. Polymeric Biomaterials [Polymethylmethacrylate, Polyethylene, Polyester, Polyvinylchloride, Silicone Rubber, Nylon, Other]
        • 7.3.1.3. Ceramic Biomaterials [Calcium Phosphate, Zirconia, Aluminum Oxide, Calcium Sulfate, Carbon, Glass]
        • 7.3.1.4. Natural Biomaterials [Hyaluronic Acid, Collagen, Gelatin, Fibrin, Cellulose, Chitin, Alginates, Silk]
      • 7.3.2. Global Biomaterials by: Application (Volume)
        • 7.3.2.1. Cardiovascular
        • 7.3.2.2. Orthopedic
        • 7.3.2.3. Ophthalmology
        • 7.3.2.4. Dental
        • 7.3.2.5. Plastic Surgery
        • 7.3.2.6. Wound Healing
        • 7.3.2.7. Tissue Engineering
        • 7.3.2.8. Neurology
        • 7.3.2.9. Others
      • 7.3.3. Global Biomaterials by: End User (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Laboratories
        • 7.3.3.3. Research Institutions
        • 7.3.3.4. Other
      • 7.3.4. Global Biomaterials Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Biomaterials (Price)
      • 7.4.1. Global Biomaterials by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Biomaterials: by Type(USD Million)
  • Table 2. Biomaterials Metallic Biomaterials [Stainless Steel, Titanium & Titanium Alloys, Cobalt-Chrome Alloys, Gold, Silver, Magnesium] , by Region USD Million (2016-2021)
  • Table 3. Biomaterials Polymeric Biomaterials [Polymethylmethacrylate, Polyethylene, Polyester, Polyvinylchloride, Silicone Rubber, Nylon, Other] , by Region USD Million (2016-2021)
  • Table 4. Biomaterials Ceramic Biomaterials [Calcium Phosphate, Zirconia, Aluminum Oxide, Calcium Sulfate, Carbon, Glass] , by Region USD Million (2016-2021)
  • Table 5. Biomaterials Natural Biomaterials [Hyaluronic Acid, Collagen, Gelatin, Fibrin, Cellulose, Chitin, Alginates, Silk] , by Region USD Million (2016-2021)
  • Table 6. Biomaterials: by Application(USD Million)
  • Table 7. Biomaterials Cardiovascular , by Region USD Million (2016-2021)
  • Table 8. Biomaterials Orthopedic , by Region USD Million (2016-2021)
  • Table 9. Biomaterials Ophthalmology , by Region USD Million (2016-2021)
  • Table 10. Biomaterials Dental , by Region USD Million (2016-2021)
  • Table 11. Biomaterials Plastic Surgery , by Region USD Million (2016-2021)
  • Table 12. Biomaterials Wound Healing , by Region USD Million (2016-2021)
  • Table 13. Biomaterials Tissue Engineering , by Region USD Million (2016-2021)
  • Table 14. Biomaterials Neurology , by Region USD Million (2016-2021)
  • Table 15. Biomaterials Others , by Region USD Million (2016-2021)
  • Table 16. Biomaterials: by End User(USD Million)
  • Table 17. Biomaterials Hospitals , by Region USD Million (2016-2021)
  • Table 18. Biomaterials Laboratories , by Region USD Million (2016-2021)
  • Table 19. Biomaterials Research Institutions , by Region USD Million (2016-2021)
  • Table 20. Biomaterials Other , by Region USD Million (2016-2021)
  • Table 21. South America Biomaterials, by Country USD Million (2016-2021)
  • Table 22. South America Biomaterials, by Type USD Million (2016-2021)
  • Table 23. South America Biomaterials, by Application USD Million (2016-2021)
  • Table 24. South America Biomaterials, by End User USD Million (2016-2021)
  • Table 25. Brazil Biomaterials, by Type USD Million (2016-2021)
  • Table 26. Brazil Biomaterials, by Application USD Million (2016-2021)
  • Table 27. Brazil Biomaterials, by End User USD Million (2016-2021)
  • Table 28. Argentina Biomaterials, by Type USD Million (2016-2021)
  • Table 29. Argentina Biomaterials, by Application USD Million (2016-2021)
  • Table 30. Argentina Biomaterials, by End User USD Million (2016-2021)
  • Table 31. Rest of South America Biomaterials, by Type USD Million (2016-2021)
  • Table 32. Rest of South America Biomaterials, by Application USD Million (2016-2021)
  • Table 33. Rest of South America Biomaterials, by End User USD Million (2016-2021)
  • Table 34. Asia Pacific Biomaterials, by Country USD Million (2016-2021)
  • Table 35. Asia Pacific Biomaterials, by Type USD Million (2016-2021)
  • Table 36. Asia Pacific Biomaterials, by Application USD Million (2016-2021)
  • Table 37. Asia Pacific Biomaterials, by End User USD Million (2016-2021)
  • Table 38. China Biomaterials, by Type USD Million (2016-2021)
  • Table 39. China Biomaterials, by Application USD Million (2016-2021)
  • Table 40. China Biomaterials, by End User USD Million (2016-2021)
  • Table 41. Japan Biomaterials, by Type USD Million (2016-2021)
  • Table 42. Japan Biomaterials, by Application USD Million (2016-2021)
  • Table 43. Japan Biomaterials, by End User USD Million (2016-2021)
  • Table 44. India Biomaterials, by Type USD Million (2016-2021)
  • Table 45. India Biomaterials, by Application USD Million (2016-2021)
  • Table 46. India Biomaterials, by End User USD Million (2016-2021)
  • Table 47. South Korea Biomaterials, by Type USD Million (2016-2021)
  • Table 48. South Korea Biomaterials, by Application USD Million (2016-2021)
  • Table 49. South Korea Biomaterials, by End User USD Million (2016-2021)
  • Table 50. Taiwan Biomaterials, by Type USD Million (2016-2021)
  • Table 51. Taiwan Biomaterials, by Application USD Million (2016-2021)
  • Table 52. Taiwan Biomaterials, by End User USD Million (2016-2021)
  • Table 53. Australia Biomaterials, by Type USD Million (2016-2021)
  • Table 54. Australia Biomaterials, by Application USD Million (2016-2021)
  • Table 55. Australia Biomaterials, by End User USD Million (2016-2021)
  • Table 56. Rest of Asia-Pacific Biomaterials, by Type USD Million (2016-2021)
  • Table 57. Rest of Asia-Pacific Biomaterials, by Application USD Million (2016-2021)
  • Table 58. Rest of Asia-Pacific Biomaterials, by End User USD Million (2016-2021)
  • Table 59. Europe Biomaterials, by Country USD Million (2016-2021)
  • Table 60. Europe Biomaterials, by Type USD Million (2016-2021)
  • Table 61. Europe Biomaterials, by Application USD Million (2016-2021)
  • Table 62. Europe Biomaterials, by End User USD Million (2016-2021)
  • Table 63. Germany Biomaterials, by Type USD Million (2016-2021)
  • Table 64. Germany Biomaterials, by Application USD Million (2016-2021)
  • Table 65. Germany Biomaterials, by End User USD Million (2016-2021)
  • Table 66. France Biomaterials, by Type USD Million (2016-2021)
  • Table 67. France Biomaterials, by Application USD Million (2016-2021)
  • Table 68. France Biomaterials, by End User USD Million (2016-2021)
  • Table 69. Italy Biomaterials, by Type USD Million (2016-2021)
  • Table 70. Italy Biomaterials, by Application USD Million (2016-2021)
  • Table 71. Italy Biomaterials, by End User USD Million (2016-2021)
  • Table 72. United Kingdom Biomaterials, by Type USD Million (2016-2021)
  • Table 73. United Kingdom Biomaterials, by Application USD Million (2016-2021)
  • Table 74. United Kingdom Biomaterials, by End User USD Million (2016-2021)
  • Table 75. Netherlands Biomaterials, by Type USD Million (2016-2021)
  • Table 76. Netherlands Biomaterials, by Application USD Million (2016-2021)
  • Table 77. Netherlands Biomaterials, by End User USD Million (2016-2021)
  • Table 78. Rest of Europe Biomaterials, by Type USD Million (2016-2021)
  • Table 79. Rest of Europe Biomaterials, by Application USD Million (2016-2021)
  • Table 80. Rest of Europe Biomaterials, by End User USD Million (2016-2021)
  • Table 81. MEA Biomaterials, by Country USD Million (2016-2021)
  • Table 82. MEA Biomaterials, by Type USD Million (2016-2021)
  • Table 83. MEA Biomaterials, by Application USD Million (2016-2021)
  • Table 84. MEA Biomaterials, by End User USD Million (2016-2021)
  • Table 85. Middle East Biomaterials, by Type USD Million (2016-2021)
  • Table 86. Middle East Biomaterials, by Application USD Million (2016-2021)
  • Table 87. Middle East Biomaterials, by End User USD Million (2016-2021)
  • Table 88. Africa Biomaterials, by Type USD Million (2016-2021)
  • Table 89. Africa Biomaterials, by Application USD Million (2016-2021)
  • Table 90. Africa Biomaterials, by End User USD Million (2016-2021)
  • Table 91. North America Biomaterials, by Country USD Million (2016-2021)
  • Table 92. North America Biomaterials, by Type USD Million (2016-2021)
  • Table 93. North America Biomaterials, by Application USD Million (2016-2021)
  • Table 94. North America Biomaterials, by End User USD Million (2016-2021)
  • Table 95. United States Biomaterials, by Type USD Million (2016-2021)
  • Table 96. United States Biomaterials, by Application USD Million (2016-2021)
  • Table 97. United States Biomaterials, by End User USD Million (2016-2021)
  • Table 98. Canada Biomaterials, by Type USD Million (2016-2021)
  • Table 99. Canada Biomaterials, by Application USD Million (2016-2021)
  • Table 100. Canada Biomaterials, by End User USD Million (2016-2021)
  • Table 101. Mexico Biomaterials, by Type USD Million (2016-2021)
  • Table 102. Mexico Biomaterials, by Application USD Million (2016-2021)
  • Table 103. Mexico Biomaterials, by End User USD Million (2016-2021)
  • Table 104. Biomaterials Sales: by Type(K Units)
  • Table 105. Biomaterials Sales Metallic Biomaterials [Stainless Steel, Titanium & Titanium Alloys, Cobalt-Chrome Alloys, Gold, Silver, Magnesium] , by Region K Units (2016-2021)
  • Table 106. Biomaterials Sales Polymeric Biomaterials [Polymethylmethacrylate, Polyethylene, Polyester, Polyvinylchloride, Silicone Rubber, Nylon, Other] , by Region K Units (2016-2021)
  • Table 107. Biomaterials Sales Ceramic Biomaterials [Calcium Phosphate, Zirconia, Aluminum Oxide, Calcium Sulfate, Carbon, Glass] , by Region K Units (2016-2021)
  • Table 108. Biomaterials Sales Natural Biomaterials [Hyaluronic Acid, Collagen, Gelatin, Fibrin, Cellulose, Chitin, Alginates, Silk] , by Region K Units (2016-2021)
  • Table 109. Biomaterials Sales: by Application(K Units)
  • Table 110. Biomaterials Sales Cardiovascular , by Region K Units (2016-2021)
  • Table 111. Biomaterials Sales Orthopedic , by Region K Units (2016-2021)
  • Table 112. Biomaterials Sales Ophthalmology , by Region K Units (2016-2021)
  • Table 113. Biomaterials Sales Dental , by Region K Units (2016-2021)
  • Table 114. Biomaterials Sales Plastic Surgery , by Region K Units (2016-2021)
  • Table 115. Biomaterials Sales Wound Healing , by Region K Units (2016-2021)
  • Table 116. Biomaterials Sales Tissue Engineering , by Region K Units (2016-2021)
  • Table 117. Biomaterials Sales Neurology , by Region K Units (2016-2021)
  • Table 118. Biomaterials Sales Others , by Region K Units (2016-2021)
  • Table 119. Biomaterials Sales: by End User(K Units)
  • Table 120. Biomaterials Sales Hospitals , by Region K Units (2016-2021)
  • Table 121. Biomaterials Sales Laboratories , by Region K Units (2016-2021)
  • Table 122. Biomaterials Sales Research Institutions , by Region K Units (2016-2021)
  • Table 123. Biomaterials Sales Other , by Region K Units (2016-2021)
  • Table 124. South America Biomaterials Sales, by Country K Units (2016-2021)
  • Table 125. South America Biomaterials Sales, by Type K Units (2016-2021)
  • Table 126. South America Biomaterials Sales, by Application K Units (2016-2021)
  • Table 127. South America Biomaterials Sales, by End User K Units (2016-2021)
  • Table 128. Brazil Biomaterials Sales, by Type K Units (2016-2021)
  • Table 129. Brazil Biomaterials Sales, by Application K Units (2016-2021)
  • Table 130. Brazil Biomaterials Sales, by End User K Units (2016-2021)
  • Table 131. Argentina Biomaterials Sales, by Type K Units (2016-2021)
  • Table 132. Argentina Biomaterials Sales, by Application K Units (2016-2021)
  • Table 133. Argentina Biomaterials Sales, by End User K Units (2016-2021)
  • Table 134. Rest of South America Biomaterials Sales, by Type K Units (2016-2021)
  • Table 135. Rest of South America Biomaterials Sales, by Application K Units (2016-2021)
  • Table 136. Rest of South America Biomaterials Sales, by End User K Units (2016-2021)
  • Table 137. Asia Pacific Biomaterials Sales, by Country K Units (2016-2021)
  • Table 138. Asia Pacific Biomaterials Sales, by Type K Units (2016-2021)
  • Table 139. Asia Pacific Biomaterials Sales, by Application K Units (2016-2021)
  • Table 140. Asia Pacific Biomaterials Sales, by End User K Units (2016-2021)
  • Table 141. China Biomaterials Sales, by Type K Units (2016-2021)
  • Table 142. China Biomaterials Sales, by Application K Units (2016-2021)
  • Table 143. China Biomaterials Sales, by End User K Units (2016-2021)
  • Table 144. Japan Biomaterials Sales, by Type K Units (2016-2021)
  • Table 145. Japan Biomaterials Sales, by Application K Units (2016-2021)
  • Table 146. Japan Biomaterials Sales, by End User K Units (2016-2021)
  • Table 147. India Biomaterials Sales, by Type K Units (2016-2021)
  • Table 148. India Biomaterials Sales, by Application K Units (2016-2021)
  • Table 149. India Biomaterials Sales, by End User K Units (2016-2021)
  • Table 150. South Korea Biomaterials Sales, by Type K Units (2016-2021)
  • Table 151. South Korea Biomaterials Sales, by Application K Units (2016-2021)
  • Table 152. South Korea Biomaterials Sales, by End User K Units (2016-2021)
  • Table 153. Taiwan Biomaterials Sales, by Type K Units (2016-2021)
  • Table 154. Taiwan Biomaterials Sales, by Application K Units (2016-2021)
  • Table 155. Taiwan Biomaterials Sales, by End User K Units (2016-2021)
  • Table 156. Australia Biomaterials Sales, by Type K Units (2016-2021)
  • Table 157. Australia Biomaterials Sales, by Application K Units (2016-2021)
  • Table 158. Australia Biomaterials Sales, by End User K Units (2016-2021)
  • Table 159. Rest of Asia-Pacific Biomaterials Sales, by Type K Units (2016-2021)
  • Table 160. Rest of Asia-Pacific Biomaterials Sales, by Application K Units (2016-2021)
  • Table 161. Rest of Asia-Pacific Biomaterials Sales, by End User K Units (2016-2021)
  • Table 162. Europe Biomaterials Sales, by Country K Units (2016-2021)
  • Table 163. Europe Biomaterials Sales, by Type K Units (2016-2021)
  • Table 164. Europe Biomaterials Sales, by Application K Units (2016-2021)
  • Table 165. Europe Biomaterials Sales, by End User K Units (2016-2021)
  • Table 166. Germany Biomaterials Sales, by Type K Units (2016-2021)
  • Table 167. Germany Biomaterials Sales, by Application K Units (2016-2021)
  • Table 168. Germany Biomaterials Sales, by End User K Units (2016-2021)
  • Table 169. France Biomaterials Sales, by Type K Units (2016-2021)
  • Table 170. France Biomaterials Sales, by Application K Units (2016-2021)
  • Table 171. France Biomaterials Sales, by End User K Units (2016-2021)
  • Table 172. Italy Biomaterials Sales, by Type K Units (2016-2021)
  • Table 173. Italy Biomaterials Sales, by Application K Units (2016-2021)
  • Table 174. Italy Biomaterials Sales, by End User K Units (2016-2021)
  • Table 175. United Kingdom Biomaterials Sales, by Type K Units (2016-2021)
  • Table 176. United Kingdom Biomaterials Sales, by Application K Units (2016-2021)
  • Table 177. United Kingdom Biomaterials Sales, by End User K Units (2016-2021)
  • Table 178. Netherlands Biomaterials Sales, by Type K Units (2016-2021)
  • Table 179. Netherlands Biomaterials Sales, by Application K Units (2016-2021)
  • Table 180. Netherlands Biomaterials Sales, by End User K Units (2016-2021)
  • Table 181. Rest of Europe Biomaterials Sales, by Type K Units (2016-2021)
  • Table 182. Rest of Europe Biomaterials Sales, by Application K Units (2016-2021)
  • Table 183. Rest of Europe Biomaterials Sales, by End User K Units (2016-2021)
  • Table 184. MEA Biomaterials Sales, by Country K Units (2016-2021)
  • Table 185. MEA Biomaterials Sales, by Type K Units (2016-2021)
  • Table 186. MEA Biomaterials Sales, by Application K Units (2016-2021)
  • Table 187. MEA Biomaterials Sales, by End User K Units (2016-2021)
  • Table 188. Middle East Biomaterials Sales, by Type K Units (2016-2021)
  • Table 189. Middle East Biomaterials Sales, by Application K Units (2016-2021)
  • Table 190. Middle East Biomaterials Sales, by End User K Units (2016-2021)
  • Table 191. Africa Biomaterials Sales, by Type K Units (2016-2021)
  • Table 192. Africa Biomaterials Sales, by Application K Units (2016-2021)
  • Table 193. Africa Biomaterials Sales, by End User K Units (2016-2021)
  • Table 194. North America Biomaterials Sales, by Country K Units (2016-2021)
  • Table 195. North America Biomaterials Sales, by Type K Units (2016-2021)
  • Table 196. North America Biomaterials Sales, by Application K Units (2016-2021)
  • Table 197. North America Biomaterials Sales, by End User K Units (2016-2021)
  • Table 198. United States Biomaterials Sales, by Type K Units (2016-2021)
  • Table 199. United States Biomaterials Sales, by Application K Units (2016-2021)
  • Table 200. United States Biomaterials Sales, by End User K Units (2016-2021)
  • Table 201. Canada Biomaterials Sales, by Type K Units (2016-2021)
  • Table 202. Canada Biomaterials Sales, by Application K Units (2016-2021)
  • Table 203. Canada Biomaterials Sales, by End User K Units (2016-2021)
  • Table 204. Mexico Biomaterials Sales, by Type K Units (2016-2021)
  • Table 205. Mexico Biomaterials Sales, by Application K Units (2016-2021)
  • Table 206. Mexico Biomaterials Sales, by End User K Units (2016-2021)
  • Table 207. Biomaterials: by Type(USD/Units)
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Company Basic Information, Sales Area and Its Competitors
  • Table 212. Company Basic Information, Sales Area and Its Competitors
  • Table 213. Company Basic Information, Sales Area and Its Competitors
  • Table 214. Company Basic Information, Sales Area and Its Competitors
  • Table 215. Company Basic Information, Sales Area and Its Competitors
  • Table 216. Company Basic Information, Sales Area and Its Competitors
  • Table 217. Company Basic Information, Sales Area and Its Competitors
  • Table 218. Biomaterials: by Type(USD Million)
  • Table 219. Biomaterials Metallic Biomaterials [Stainless Steel, Titanium & Titanium Alloys, Cobalt-Chrome Alloys, Gold, Silver, Magnesium] , by Region USD Million (2022-2027)
  • Table 220. Biomaterials Polymeric Biomaterials [Polymethylmethacrylate, Polyethylene, Polyester, Polyvinylchloride, Silicone Rubber, Nylon, Other] , by Region USD Million (2022-2027)
  • Table 221. Biomaterials Ceramic Biomaterials [Calcium Phosphate, Zirconia, Aluminum Oxide, Calcium Sulfate, Carbon, Glass] , by Region USD Million (2022-2027)
  • Table 222. Biomaterials Natural Biomaterials [Hyaluronic Acid, Collagen, Gelatin, Fibrin, Cellulose, Chitin, Alginates, Silk] , by Region USD Million (2022-2027)
  • Table 223. Biomaterials: by Application(USD Million)
  • Table 224. Biomaterials Cardiovascular , by Region USD Million (2022-2027)
  • Table 225. Biomaterials Orthopedic , by Region USD Million (2022-2027)
  • Table 226. Biomaterials Ophthalmology , by Region USD Million (2022-2027)
  • Table 227. Biomaterials Dental , by Region USD Million (2022-2027)
  • Table 228. Biomaterials Plastic Surgery , by Region USD Million (2022-2027)
  • Table 229. Biomaterials Wound Healing , by Region USD Million (2022-2027)
  • Table 230. Biomaterials Tissue Engineering , by Region USD Million (2022-2027)
  • Table 231. Biomaterials Neurology , by Region USD Million (2022-2027)
  • Table 232. Biomaterials Others , by Region USD Million (2022-2027)
  • Table 233. Biomaterials: by End User(USD Million)
  • Table 234. Biomaterials Hospitals , by Region USD Million (2022-2027)
  • Table 235. Biomaterials Laboratories , by Region USD Million (2022-2027)
  • Table 236. Biomaterials Research Institutions , by Region USD Million (2022-2027)
  • Table 237. Biomaterials Other , by Region USD Million (2022-2027)
  • Table 238. South America Biomaterials, by Country USD Million (2022-2027)
  • Table 239. South America Biomaterials, by Type USD Million (2022-2027)
  • Table 240. South America Biomaterials, by Application USD Million (2022-2027)
  • Table 241. South America Biomaterials, by End User USD Million (2022-2027)
  • Table 242. Brazil Biomaterials, by Type USD Million (2022-2027)
  • Table 243. Brazil Biomaterials, by Application USD Million (2022-2027)
  • Table 244. Brazil Biomaterials, by End User USD Million (2022-2027)
  • Table 245. Argentina Biomaterials, by Type USD Million (2022-2027)
  • Table 246. Argentina Biomaterials, by Application USD Million (2022-2027)
  • Table 247. Argentina Biomaterials, by End User USD Million (2022-2027)
  • Table 248. Rest of South America Biomaterials, by Type USD Million (2022-2027)
  • Table 249. Rest of South America Biomaterials, by Application USD Million (2022-2027)
  • Table 250. Rest of South America Biomaterials, by End User USD Million (2022-2027)
  • Table 251. Asia Pacific Biomaterials, by Country USD Million (2022-2027)
  • Table 252. Asia Pacific Biomaterials, by Type USD Million (2022-2027)
  • Table 253. Asia Pacific Biomaterials, by Application USD Million (2022-2027)
  • Table 254. Asia Pacific Biomaterials, by End User USD Million (2022-2027)
  • Table 255. China Biomaterials, by Type USD Million (2022-2027)
  • Table 256. China Biomaterials, by Application USD Million (2022-2027)
  • Table 257. China Biomaterials, by End User USD Million (2022-2027)
  • Table 258. Japan Biomaterials, by Type USD Million (2022-2027)
  • Table 259. Japan Biomaterials, by Application USD Million (2022-2027)
  • Table 260. Japan Biomaterials, by End User USD Million (2022-2027)
  • Table 261. India Biomaterials, by Type USD Million (2022-2027)
  • Table 262. India Biomaterials, by Application USD Million (2022-2027)
  • Table 263. India Biomaterials, by End User USD Million (2022-2027)
  • Table 264. South Korea Biomaterials, by Type USD Million (2022-2027)
  • Table 265. South Korea Biomaterials, by Application USD Million (2022-2027)
  • Table 266. South Korea Biomaterials, by End User USD Million (2022-2027)
  • Table 267. Taiwan Biomaterials, by Type USD Million (2022-2027)
  • Table 268. Taiwan Biomaterials, by Application USD Million (2022-2027)
  • Table 269. Taiwan Biomaterials, by End User USD Million (2022-2027)
  • Table 270. Australia Biomaterials, by Type USD Million (2022-2027)
  • Table 271. Australia Biomaterials, by Application USD Million (2022-2027)
  • Table 272. Australia Biomaterials, by End User USD Million (2022-2027)
  • Table 273. Rest of Asia-Pacific Biomaterials, by Type USD Million (2022-2027)
  • Table 274. Rest of Asia-Pacific Biomaterials, by Application USD Million (2022-2027)
  • Table 275. Rest of Asia-Pacific Biomaterials, by End User USD Million (2022-2027)
  • Table 276. Europe Biomaterials, by Country USD Million (2022-2027)
  • Table 277. Europe Biomaterials, by Type USD Million (2022-2027)
  • Table 278. Europe Biomaterials, by Application USD Million (2022-2027)
  • Table 279. Europe Biomaterials, by End User USD Million (2022-2027)
  • Table 280. Germany Biomaterials, by Type USD Million (2022-2027)
  • Table 281. Germany Biomaterials, by Application USD Million (2022-2027)
  • Table 282. Germany Biomaterials, by End User USD Million (2022-2027)
  • Table 283. France Biomaterials, by Type USD Million (2022-2027)
  • Table 284. France Biomaterials, by Application USD Million (2022-2027)
  • Table 285. France Biomaterials, by End User USD Million (2022-2027)
  • Table 286. Italy Biomaterials, by Type USD Million (2022-2027)
  • Table 287. Italy Biomaterials, by Application USD Million (2022-2027)
  • Table 288. Italy Biomaterials, by End User USD Million (2022-2027)
  • Table 289. United Kingdom Biomaterials, by Type USD Million (2022-2027)
  • Table 290. United Kingdom Biomaterials, by Application USD Million (2022-2027)
  • Table 291. United Kingdom Biomaterials, by End User USD Million (2022-2027)
  • Table 292. Netherlands Biomaterials, by Type USD Million (2022-2027)
  • Table 293. Netherlands Biomaterials, by Application USD Million (2022-2027)
  • Table 294. Netherlands Biomaterials, by End User USD Million (2022-2027)
  • Table 295. Rest of Europe Biomaterials, by Type USD Million (2022-2027)
  • Table 296. Rest of Europe Biomaterials, by Application USD Million (2022-2027)
  • Table 297. Rest of Europe Biomaterials, by End User USD Million (2022-2027)
  • Table 298. MEA Biomaterials, by Country USD Million (2022-2027)
  • Table 299. MEA Biomaterials, by Type USD Million (2022-2027)
  • Table 300. MEA Biomaterials, by Application USD Million (2022-2027)
  • Table 301. MEA Biomaterials, by End User USD Million (2022-2027)
  • Table 302. Middle East Biomaterials, by Type USD Million (2022-2027)
  • Table 303. Middle East Biomaterials, by Application USD Million (2022-2027)
  • Table 304. Middle East Biomaterials, by End User USD Million (2022-2027)
  • Table 305. Africa Biomaterials, by Type USD Million (2022-2027)
  • Table 306. Africa Biomaterials, by Application USD Million (2022-2027)
  • Table 307. Africa Biomaterials, by End User USD Million (2022-2027)
  • Table 308. North America Biomaterials, by Country USD Million (2022-2027)
  • Table 309. North America Biomaterials, by Type USD Million (2022-2027)
  • Table 310. North America Biomaterials, by Application USD Million (2022-2027)
  • Table 311. North America Biomaterials, by End User USD Million (2022-2027)
  • Table 312. United States Biomaterials, by Type USD Million (2022-2027)
  • Table 313. United States Biomaterials, by Application USD Million (2022-2027)
  • Table 314. United States Biomaterials, by End User USD Million (2022-2027)
  • Table 315. Canada Biomaterials, by Type USD Million (2022-2027)
  • Table 316. Canada Biomaterials, by Application USD Million (2022-2027)
  • Table 317. Canada Biomaterials, by End User USD Million (2022-2027)
  • Table 318. Mexico Biomaterials, by Type USD Million (2022-2027)
  • Table 319. Mexico Biomaterials, by Application USD Million (2022-2027)
  • Table 320. Mexico Biomaterials, by End User USD Million (2022-2027)
  • Table 321. Biomaterials Sales: by Type(K Units)
  • Table 322. Biomaterials Sales Metallic Biomaterials [Stainless Steel, Titanium & Titanium Alloys, Cobalt-Chrome Alloys, Gold, Silver, Magnesium] , by Region K Units (2022-2027)
  • Table 323. Biomaterials Sales Polymeric Biomaterials [Polymethylmethacrylate, Polyethylene, Polyester, Polyvinylchloride, Silicone Rubber, Nylon, Other] , by Region K Units (2022-2027)
  • Table 324. Biomaterials Sales Ceramic Biomaterials [Calcium Phosphate, Zirconia, Aluminum Oxide, Calcium Sulfate, Carbon, Glass] , by Region K Units (2022-2027)
  • Table 325. Biomaterials Sales Natural Biomaterials [Hyaluronic Acid, Collagen, Gelatin, Fibrin, Cellulose, Chitin, Alginates, Silk] , by Region K Units (2022-2027)
  • Table 326. Biomaterials Sales: by Application(K Units)
  • Table 327. Biomaterials Sales Cardiovascular , by Region K Units (2022-2027)
  • Table 328. Biomaterials Sales Orthopedic , by Region K Units (2022-2027)
  • Table 329. Biomaterials Sales Ophthalmology , by Region K Units (2022-2027)
  • Table 330. Biomaterials Sales Dental , by Region K Units (2022-2027)
  • Table 331. Biomaterials Sales Plastic Surgery , by Region K Units (2022-2027)
  • Table 332. Biomaterials Sales Wound Healing , by Region K Units (2022-2027)
  • Table 333. Biomaterials Sales Tissue Engineering , by Region K Units (2022-2027)
  • Table 334. Biomaterials Sales Neurology , by Region K Units (2022-2027)
  • Table 335. Biomaterials Sales Others , by Region K Units (2022-2027)
  • Table 336. Biomaterials Sales: by End User(K Units)
  • Table 337. Biomaterials Sales Hospitals , by Region K Units (2022-2027)
  • Table 338. Biomaterials Sales Laboratories , by Region K Units (2022-2027)
  • Table 339. Biomaterials Sales Research Institutions , by Region K Units (2022-2027)
  • Table 340. Biomaterials Sales Other , by Region K Units (2022-2027)
  • Table 341. South America Biomaterials Sales, by Country K Units (2022-2027)
  • Table 342. South America Biomaterials Sales, by Type K Units (2022-2027)
  • Table 343. South America Biomaterials Sales, by Application K Units (2022-2027)
  • Table 344. South America Biomaterials Sales, by End User K Units (2022-2027)
  • Table 345. Brazil Biomaterials Sales, by Type K Units (2022-2027)
  • Table 346. Brazil Biomaterials Sales, by Application K Units (2022-2027)
  • Table 347. Brazil Biomaterials Sales, by End User K Units (2022-2027)
  • Table 348. Argentina Biomaterials Sales, by Type K Units (2022-2027)
  • Table 349. Argentina Biomaterials Sales, by Application K Units (2022-2027)
  • Table 350. Argentina Biomaterials Sales, by End User K Units (2022-2027)
  • Table 351. Rest of South America Biomaterials Sales, by Type K Units (2022-2027)
  • Table 352. Rest of South America Biomaterials Sales, by Application K Units (2022-2027)
  • Table 353. Rest of South America Biomaterials Sales, by End User K Units (2022-2027)
  • Table 354. Asia Pacific Biomaterials Sales, by Country K Units (2022-2027)
  • Table 355. Asia Pacific Biomaterials Sales, by Type K Units (2022-2027)
  • Table 356. Asia Pacific Biomaterials Sales, by Application K Units (2022-2027)
  • Table 357. Asia Pacific Biomaterials Sales, by End User K Units (2022-2027)
  • Table 358. China Biomaterials Sales, by Type K Units (2022-2027)
  • Table 359. China Biomaterials Sales, by Application K Units (2022-2027)
  • Table 360. China Biomaterials Sales, by End User K Units (2022-2027)
  • Table 361. Japan Biomaterials Sales, by Type K Units (2022-2027)
  • Table 362. Japan Biomaterials Sales, by Application K Units (2022-2027)
  • Table 363. Japan Biomaterials Sales, by End User K Units (2022-2027)
  • Table 364. India Biomaterials Sales, by Type K Units (2022-2027)
  • Table 365. India Biomaterials Sales, by Application K Units (2022-2027)
  • Table 366. India Biomaterials Sales, by End User K Units (2022-2027)
  • Table 367. South Korea Biomaterials Sales, by Type K Units (2022-2027)
  • Table 368. South Korea Biomaterials Sales, by Application K Units (2022-2027)
  • Table 369. South Korea Biomaterials Sales, by End User K Units (2022-2027)
  • Table 370. Taiwan Biomaterials Sales, by Type K Units (2022-2027)
  • Table 371. Taiwan Biomaterials Sales, by Application K Units (2022-2027)
  • Table 372. Taiwan Biomaterials Sales, by End User K Units (2022-2027)
  • Table 373. Australia Biomaterials Sales, by Type K Units (2022-2027)
  • Table 374. Australia Biomaterials Sales, by Application K Units (2022-2027)
  • Table 375. Australia Biomaterials Sales, by End User K Units (2022-2027)
  • Table 376. Rest of Asia-Pacific Biomaterials Sales, by Type K Units (2022-2027)
  • Table 377. Rest of Asia-Pacific Biomaterials Sales, by Application K Units (2022-2027)
  • Table 378. Rest of Asia-Pacific Biomaterials Sales, by End User K Units (2022-2027)
  • Table 379. Europe Biomaterials Sales, by Country K Units (2022-2027)
  • Table 380. Europe Biomaterials Sales, by Type K Units (2022-2027)
  • Table 381. Europe Biomaterials Sales, by Application K Units (2022-2027)
  • Table 382. Europe Biomaterials Sales, by End User K Units (2022-2027)
  • Table 383. Germany Biomaterials Sales, by Type K Units (2022-2027)
  • Table 384. Germany Biomaterials Sales, by Application K Units (2022-2027)
  • Table 385. Germany Biomaterials Sales, by End User K Units (2022-2027)
  • Table 386. France Biomaterials Sales, by Type K Units (2022-2027)
  • Table 387. France Biomaterials Sales, by Application K Units (2022-2027)
  • Table 388. France Biomaterials Sales, by End User K Units (2022-2027)
  • Table 389. Italy Biomaterials Sales, by Type K Units (2022-2027)
  • Table 390. Italy Biomaterials Sales, by Application K Units (2022-2027)
  • Table 391. Italy Biomaterials Sales, by End User K Units (2022-2027)
  • Table 392. United Kingdom Biomaterials Sales, by Type K Units (2022-2027)
  • Table 393. United Kingdom Biomaterials Sales, by Application K Units (2022-2027)
  • Table 394. United Kingdom Biomaterials Sales, by End User K Units (2022-2027)
  • Table 395. Netherlands Biomaterials Sales, by Type K Units (2022-2027)
  • Table 396. Netherlands Biomaterials Sales, by Application K Units (2022-2027)
  • Table 397. Netherlands Biomaterials Sales, by End User K Units (2022-2027)
  • Table 398. Rest of Europe Biomaterials Sales, by Type K Units (2022-2027)
  • Table 399. Rest of Europe Biomaterials Sales, by Application K Units (2022-2027)
  • Table 400. Rest of Europe Biomaterials Sales, by End User K Units (2022-2027)
  • Table 401. MEA Biomaterials Sales, by Country K Units (2022-2027)
  • Table 402. MEA Biomaterials Sales, by Type K Units (2022-2027)
  • Table 403. MEA Biomaterials Sales, by Application K Units (2022-2027)
  • Table 404. MEA Biomaterials Sales, by End User K Units (2022-2027)
  • Table 405. Middle East Biomaterials Sales, by Type K Units (2022-2027)
  • Table 406. Middle East Biomaterials Sales, by Application K Units (2022-2027)
  • Table 407. Middle East Biomaterials Sales, by End User K Units (2022-2027)
  • Table 408. Africa Biomaterials Sales, by Type K Units (2022-2027)
  • Table 409. Africa Biomaterials Sales, by Application K Units (2022-2027)
  • Table 410. Africa Biomaterials Sales, by End User K Units (2022-2027)
  • Table 411. North America Biomaterials Sales, by Country K Units (2022-2027)
  • Table 412. North America Biomaterials Sales, by Type K Units (2022-2027)
  • Table 413. North America Biomaterials Sales, by Application K Units (2022-2027)
  • Table 414. North America Biomaterials Sales, by End User K Units (2022-2027)
  • Table 415. United States Biomaterials Sales, by Type K Units (2022-2027)
  • Table 416. United States Biomaterials Sales, by Application K Units (2022-2027)
  • Table 417. United States Biomaterials Sales, by End User K Units (2022-2027)
  • Table 418. Canada Biomaterials Sales, by Type K Units (2022-2027)
  • Table 419. Canada Biomaterials Sales, by Application K Units (2022-2027)
  • Table 420. Canada Biomaterials Sales, by End User K Units (2022-2027)
  • Table 421. Mexico Biomaterials Sales, by Type K Units (2022-2027)
  • Table 422. Mexico Biomaterials Sales, by Application K Units (2022-2027)
  • Table 423. Mexico Biomaterials Sales, by End User K Units (2022-2027)
  • Table 424. Biomaterials: by Type(USD/Units)
  • Table 425. Research Programs/Design for This Report
  • Table 426. Key Data Information from Secondary Sources
  • Table 427. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Biomaterials: by Type USD Million (2016-2021)
  • Figure 5. Global Biomaterials: by Application USD Million (2016-2021)
  • Figure 6. Global Biomaterials: by End User USD Million (2016-2021)
  • Figure 7. South America Biomaterials Share (%), by Country
  • Figure 8. Asia Pacific Biomaterials Share (%), by Country
  • Figure 9. Europe Biomaterials Share (%), by Country
  • Figure 10. MEA Biomaterials Share (%), by Country
  • Figure 11. North America Biomaterials Share (%), by Country
  • Figure 12. Global Biomaterials: by Type K Units (2016-2021)
  • Figure 13. Global Biomaterials: by Application K Units (2016-2021)
  • Figure 14. Global Biomaterials: by End User K Units (2016-2021)
  • Figure 15. South America Biomaterials Share (%), by Country
  • Figure 16. Asia Pacific Biomaterials Share (%), by Country
  • Figure 17. Europe Biomaterials Share (%), by Country
  • Figure 18. MEA Biomaterials Share (%), by Country
  • Figure 19. North America Biomaterials Share (%), by Country
  • Figure 20. Global Biomaterials: by Type USD/Units (2016-2021)
  • Figure 21. Global Biomaterials share by Players 2021 (%)
  • Figure 22. Global Biomaterials share by Players (Top 3) 2021(%)
  • Figure 23. Global Biomaterials share by Players (Top 5) 2021(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Royal DSM (Netherlands) Revenue, Net Income and Gross profit
  • Figure 26. Royal DSM (Netherlands) Revenue: by Geography 2021
  • Figure 27. BASF SE (Germany) Revenue, Net Income and Gross profit
  • Figure 28. BASF SE (Germany) Revenue: by Geography 2021
  • Figure 29. Corbion (Netherlands) Revenue, Net Income and Gross profit
  • Figure 30. Corbion (Netherlands) Revenue: by Geography 2021
  • Figure 31. Evonik Industries (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Evonik Industries (Germany) Revenue: by Geography 2021
  • Figure 33. Zimmer Biomet Holdings, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Zimmer Biomet Holdings, Inc. (United States) Revenue: by Geography 2021
  • Figure 35. Berkeley Advanced Biomaterials (United States) Revenue, Net Income and Gross profit
  • Figure 36. Berkeley Advanced Biomaterials (United States) Revenue: by Geography 2021
  • Figure 37. Cam Bioceramics B.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 38. Cam Bioceramics B.V. (Netherlands) Revenue: by Geography 2021
  • Figure 39. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 40. Bayer AG (Germany) Revenue: by Geography 2021
  • Figure 41. Collagen Matrix, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Collagen Matrix, Inc. (United States) Revenue: by Geography 2021
  • Figure 43. Victrex plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 44. Victrex plc (United Kingdom) Revenue: by Geography 2021
  • Figure 45. Global Biomaterials: by Type USD Million (2022-2027)
  • Figure 46. Global Biomaterials: by Application USD Million (2022-2027)
  • Figure 47. Global Biomaterials: by End User USD Million (2022-2027)
  • Figure 48. South America Biomaterials Share (%), by Country
  • Figure 49. Asia Pacific Biomaterials Share (%), by Country
  • Figure 50. Europe Biomaterials Share (%), by Country
  • Figure 51. MEA Biomaterials Share (%), by Country
  • Figure 52. North America Biomaterials Share (%), by Country
  • Figure 53. Global Biomaterials: by Type K Units (2022-2027)
  • Figure 54. Global Biomaterials: by Application K Units (2022-2027)
  • Figure 55. Global Biomaterials: by End User K Units (2022-2027)
  • Figure 56. South America Biomaterials Share (%), by Country
  • Figure 57. Asia Pacific Biomaterials Share (%), by Country
  • Figure 58. Europe Biomaterials Share (%), by Country
  • Figure 59. MEA Biomaterials Share (%), by Country
  • Figure 60. North America Biomaterials Share (%), by Country
  • Figure 61. Global Biomaterials: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Royal DSM (Netherlands)
  • BASF SE (Germany)
  • Corbion (Netherlands)
  • Evonik Industries (Germany)
  • Zimmer Biomet Holdings, Inc. (United States)
  • Berkeley Advanced Biomaterials (United States)
  • Cam Bioceramics B.V. (Netherlands)
  • Bayer AG (Germany)
  • Collagen Matrix, Inc. (United States)
  • Victrex plc (United Kingdom)
Additional players considered in the study are as follows:
Noble Biomaterials Inc. (United States) , Covalon Technologies Ltd. (Canada)
Select User Access Type

Key Highlights of Report


Jan 2022 248 Pages 83 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Biomaterials Market Quantitative research analysis
Global Biomaterials Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Biomaterials market is expected to see a CAGR of % during projected year 2021 to 2027.
Top performing companies in the Global Biomaterials market are Royal DSM (Netherlands), BASF SE (Germany), Corbion (Netherlands), Evonik Industries (Germany), Zimmer Biomet Holdings, Inc. (United States), Berkeley Advanced Biomaterials (United States), Cam Bioceramics B.V. (Netherlands), Bayer AG (Germany), Collagen Matrix, Inc. (United States) and Victrex plc (United Kingdom), to name a few.
is dominating the Biomaterials Market.

Know More About Global Biomaterials Market Report?

Have a Query? Click Here

Other Related Reports

Insulin Syringes Comprehensive Study by Type (3/10 cc syringe, 1/2 cc syringe, 1 cc syringe, Others), Application (Hospital, Home Care, Others) Players and Region - Global Market Outlook to 2030
$ 3500
Ductless Fume Hoods Comprehensive Study by Type (Standard Model, With Secondary Carbon Filter, With Secondary HEPA Filter), Application (Undergraduate Teaching Labs, Industrial and Biomedical Researc...
$ 3750
Medical Tuning Fork Comprehensive Study by Type (Hartmann, Rydel-Seiffer, Others), Application (Hospitals, Clinics, Ambulatory surgical centers, Others), Material (Steel Material, Aluminum Alloy Mat...
$ 3450
Silicone Hydrogel Contact Lenses Comprehensive Study by Type (Spherical Form, Toric Form, Multifocal Form), Application (Hospital Pharmacies, Optical Shop, Online Stores, Others), Design Type (Spheri...
$ 3450
Ultrasound Imaging Comprehensive Study by Type (Grey Scale Imaging {A-Mode, B-Mode, M-Mode}, Doppler Imaging {Continuous wave Doppler, Power Doppler, Color Doppler, Duplex Doppler, Pulsed wave Dopple...
$ 3800
Eeg Electrodes Comprehensive Study by Type (Needle Electrodes, Patch Electrodes, Others), Application (Diagnostic Electrodes, Therapeutic Electrodes, Others), End Users (Hospitals, Academic & Researc...
$ 3350